Baird Medical Investment Holdings (BDMD) Non-Current Deferred Tax Liability (2024 - 2025)
Baird Medical Investment Holdings' quarterly Non-Current Deferred Tax Liability came in at $21559.0 in Q2 2025, down 52.34% quarter-over-quarter from $45238.0 in Q4 2024.
Baird Medical Investment Holdings has reported Non-Current Deferred Tax Liability for 2 years, with the latest figure at $21559.0 in Q2 2025.
- For the quarter ending Q2 2025, Non-Current Deferred Tax Liability changed N/A year-over-year to $21559.0; the trailing twelve-month figure through Jun 2025 stood at $21559.0 (changed N/A YoY), and the FY2024 full-year result was $45238.0, changed N/A from the prior year.
- Non-Current Deferred Tax Liability for Q2 2025 stood at $21559.0, down from $45238.0 in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $45238.0 in Q4 2024, with the low at $21559.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Baird Medical Investment Holdings | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 21,559.00 |
| Jun 30, 2025 | 21,559.00 |
| Dec 31, 2024 | 45,238.00 |
| Dec 31, 2024 | 45,238.00 |